ALGN — Align Technology, Inc.

Align Technology (ALGN) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenues: $1.04 billion, up 6.2% year-over-year.
• Clear Aligner Revenues: $856 million, up 7.4% year-over-year.
• Clear Aligner Shipments: 686,000 cases, a record and up 6.7% year-over-year.
• Gross Margin: 70.8%, an increase of 1.4 points year-over-year; non-GAAP gross margin at 71.8%.
• Operating Income: $142 million, with an operating margin of 13.6%; non-GAAP operating margin at 21.5%.
• Net Income per Diluted Share: $1.57, up from $1.26 year-over-year; non-GAAP EPS at $2.58, a 21% increase.
• Cash Flow from Operations: $151 million; free cash flow of $120.3 million.
• Cash and Cash Equivalents: $1.06 billion, with $800 million available for stock repurchases.

2. Strategic Updates and Business Highlights

• Continued strong demand for Clear Aligners across all patient demographics, particularly in international markets (EMEA, APAC, and Latin America).
• Successful adoption of new products like Invisalign First and the Invisalign Palate Expander (IPE) for growing patients.
• Growth in the DSO (Dental Service Organizations) channel, which accounted for about 25% of total global volumes.
• Expansion of the Doctor Subscription Program (DSP) and patient financing options, enhancing affordability and patient conversion.
• Introduction of the Invisalign Advanced Restorative Treatment (ART) pilot in the U.S. to integrate orthodontics with restorative dentistry.
• Ongoing investments in technology upgrades and manufacturing capacity.

3. Forward Guidance and Outlook

• Q2 2026 Revenue Guidance: Expected between $1.040 billion and $1.060 billion, representing a 3% to 5% year-over-year growth.
• 2026 Full-Year Revenue Growth: Projected at 3% to 4% year-over-year, with mid-single-digit growth in Clear Aligner volumes.
• Operating Margin Guidance: GAAP operating margin expected at approximately 16.4%, non-GAAP at about 21.5%.
• Anticipated capital expenditures for 2026 between $125 million and $150 million.

4. Bad News, Challenges, or Points of Concern

• Geopolitical Risks: Ongoing military action in the Middle East poses potential risks to patient traffic and consumer demand, particularly affecting EMEA markets.
• North America Performance: Decline in North American Clear Aligner volumes, attributed to macroeconomic factors and less patient traffic in retail channels.
• ASP Trends: Average selling prices expected to decline by 1% to 2% for the year due to product and country mix shifts.
• Operating Expenses: Increased operating expenses by 8.3% year-over-year, primarily due to legal settlements and higher employee compensation.

5. Notable Q&A Insights

• Management confirmed that the Middle East contributes a small percentage to overall revenues, but the geopolitical situation could impact broader consumer sentiment and inflation.
• The U.S. market is experiencing slower growth compared to international markets, with DSO channels performing significantly better than retail.
• The rollout of new products like Zero AA (NOAA) is ongoing, with gradual adoption expected, but not significantly impacting 2026 guidance.
• Management emphasized a disciplined approach to share repurchases, balancing cash returns to shareholders with investments in growth.

Overall, Align Technology reported a solid quarter with strong international performance, but faces challenges in North America and potential geopolitical risks that could impact future growth.